Yves R.
- Country
- France
- Department
- oncology
Research Overview
- Evaluation of Oxaliplatin-Based Chemotherapy for Lean Body Mass Normalization in Patients with Colon Cancer
- Ezurpimtrostat autophagy inhibitor in association with Atezolizumab-Bevacizumab in first line treatment of unresectable hepatocellular carcinoma, a phase 2b randomized trial. ABE-LIVER
- Phase III Multicentric Study on Chemotherapy Efficacy in Stage III Colorectal Cancer with Positive ctDNA Post-Surgery Using Irinotecan and Drug Combination
Data & Insights
Has run more than one trial at 106 of 218 partner sites.
Specializations
Gastrointestinal Oncology
Specializes in treating colorectal cancer with particular emphasis on innovative treatment approaches for both early-stage and metastatic disease. Investigates personalized therapeutic strategies using circulating tumor DNA for treatment decision-making in colon cancer.
- Stage II and III colon cancer management
- Metastatic colorectal cancer treatment
- Adjuvant therapy optimization
Hepatobiliary and Pancreatic Oncology
Focuses on developing treatments for hepatocellular carcinoma and pancreatic adenocarcinoma. Explores novel therapeutic combinations including targeted therapies and immunotherapy approaches for these challenging diseases.
- Advanced liver cancer treatments
- Pancreatic cancer therapeutic strategies
- Biliary tract carcinoma management
Precision Medicine
Leads investigations in biomarker-driven treatments with particular attention to molecular profiling and targeted therapies. Specializes in developing personalized treatment approaches for elderly patients with gastrointestinal cancers.
- Molecular-guided therapy selection
- Neoadjuvant treatment strategies
- Age-adapted therapeutic approaches
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.